Evaluation of a Novel TB Drug SQ109 to Shorten and Simplify the treatment of Experimental Tuberculosis (TB) SQ109 (ethambutol analogue) is a novel drug undergoing development for treatment of drug-resistant tuberculosis. 1.1.1 Pharmacokinetic properties of SQ109 Pharmacokinetic characteristics of SQ109, received on preclinical trial show evidence of relatively high efficiency even on the onset of…… Read More »


© 2024 Medcoi LLC, all rights reserved.
go to top